Research from Redeye, Redeye AB

Redeye

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen). 

Expertise in Denmark, Finland, Norway and Sweden.

Research from Redeye

Redeye AB

Specialists in innovative and fast-growing Nordic companies within Life Science and Technology.

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen).

Equity Bottom-Up

<ul><li>Stille's Q2 2026 report beat our estimates on sales by ~7%, but showed softer margins than we had pencilled in, with EBIT margin of 15% versus our 18% estimate.</li><li>The margin miss miss was primarily driven by mix and integration costs while the organic growth of 27% was comfortably ahead of our 21% forecast.</li></ul>

Stille's Q2 2026 report beat our estimates on sales by ~7%, but showed softer margins than we had pencilled in, with EBIT margin of 15% versus our 18% estimate.The margin miss miss was primarily driven by mix and integration costs while the organic growth of 27% was comfortably ahead of our 21% forecast.

Stille (Q2 initial take): Sales beat with softer margins